focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLendinvest Regulatory News (LINV)

Share Price Information for Lendinvest (LINV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 28.50
Bid: 28.00
Ask: 29.00
Change: 0.00 (0.00%)
Spread: 1.00 (3.571%)
Open: 28.50
High: 28.50
Low: 28.50
Prev. Close: 28.50
LINV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Terms Confirmation

28 Sep 2023 08:19

RNS Number : 9851N
LendInvest Secured Income II
28 September 2023
 

The information contained herein may only be released, published or distributed in the United Kingdom, the Isle of Man, Jersey and the Bailiwick of Guernsey in accordance with applicable regulatory requirements. The information contained herein is not for release, publication or distribution in or into the United States, Australia, Canada, Japan, South Africa, the Republic of Ireland or in any other jurisdiction where it is unlawful to distribute this document.

UK MiFIR retail investors, professional investors and ECPs target market - Manufacturer target market (UK MiFIR product governance) is eligible counterparties and professional clients (all distribution channels) and also retail clients (all distribution channels).

28 September 2023

LENDINVEST SECURED INCOME II PLC

£60,000,000 11.5 per cent. Notes due 2026with the benefit of a partial 20% guarantee by LendInvest plc

Final Terms Confirmation Announcement and Announcement of Results of Exchange Offer

This announcement constitutes the Final Terms Confirmation Announcement referred to in (a) the exchange offer memorandum and prospectus dated 13 September 2023 (the "Exchange Offer Memorandum and Prospectus") relating to (i) the proposed offer and issue (the "Cash Offer") by LendInvest Secured Income II plc (the "Issuer") of its 11.5 per cent. notes due 2026 (the "New Bonds"); and (ii) the Issuer's invitation to exchange (the "Exchange Offer") to holders of the 5.375 per cent. Notes due 2023 (the "Existing Bonds") issued by LendInvest Secured Income plc for the Issuer's 11.5 per cent. notes due 2026 (the "Exchange New Bonds" and together with the New Bonds, the "Notes") and (b) the summary relating to the offer of the Notes to be issued by the Issuer (the "Summary"). The Notes will be issued as one series on the Issue Date (as specified below) with ISIN XS2677624657.

This announcement also announces the results of the Exchange Offer referred to in the Exchange Offer Memorandum and Prospectus.

This announcement must be read in conjunction with the Exchange Offer Memorandum and Prospectus, the Summary, the base prospectus dated 12 September 2023 relating to the Euro Medium Term Note Programme established by the Issuer (the "Base Prospectus") and the final terms dated 13 September 2023 in connection with the issuance of the Notes (the "Final Terms").

Each of the Exchange Offer Memorandum and Prospectus, the Summary, the Base Prospectus and the Final Terms is available for viewing at the website of LendInvest plc (https://www.lendinvest.com/ bond4).

The Exchange Offer Period relating to the Exchange Offer and the Offer Period relating to the Cash Offer, in each case, expired at 4.00 p.m. (London time) on 27 September 2023 and accordingly the Notes can no longer be subscribed for nor be obtained by way of application for exchange. Accordingly, this announcement is not an offer to subscribe, tender, sell or exchange any securities.

The Issuer confirms the following for the purposes of this Final Terms Confirmation Announcement:

Issue Date:

3 October 2023

Aggregate nominal amount of the Notes to be issued:

£60,000,000 (of which £7,314,500 were subscribed pursuant to the Cash Offer, £31,685,500 were subscribed pursuant to the Exchange Offer and £21,000,000 will be initially retained in treasury by the Issuer)

Estimated net proceeds of the New Bonds:

£37,969,395 (taking into account of fees and commissions payable)

Estimated total expenses of the offering:

£438,750 (being the fees and commissions payable to the Dealer Manager in relation to the Notes and marketing costs)

Expenses relating to the offering and admission to trading of the Notes:

£1,030,605

In relation to the Exchange Offer, the aggregate nominal amount of the Existing Bonds accepted for exchange by the Issuer is £31,685,500. Accordingly, the aggregate nominal amount of the Existing Bonds remaining outstanding (and falling due to be repaid by the Issuer on the maturity date) after the Exchange Offer will be £23,316,500.

This announcement is not a prospectus for the purposes of Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (the "EUWA") (the "UK Prospectus Regulation") and/or Part VI of the Financial Services and Markets Act 2000.

Investors should not subscribe for any Notes referred to in this announcement except on the basis of information in the Base Prospectus, the Final Terms and, in relation to the Exchange Offer, the Exchange Offer Memorandum and Prospectus before making an investment decision in order to fully understand the potential risks and rewards associated with the decision to invest in the New Bonds and/or participate in the Exchange Offer. Investors should not subscribe for any bonds referred to in this announcement except on the basis of information in the Base Prospectus, the Final Terms and the Exchange Offer Memorandum and Prospectus.

Please note that the information contained in the Base Prospectus, the Final Terms and the Exchange Offer Memorandum and Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus, the Final Terms and/or the Exchange Offer Memorandum and Prospectus) only and is not intended for use, and should not be relied upon, by any person outside these countries and/or to whom the offer contained in the Base Prospectus, the Final Terms and/or the Exchange Offer Memorandum and Prospectus is not addressed. Prior to relying on the information contained in the Base Prospectus, the Final Terms and the Exchange Offer Memorandum and Prospectus you must ascertain from the Base Prospectus, the Final Terms and the Exchange Offer Memorandum and Prospectus (as applicable) whether or not you are part of the intended addressees of the information contained therein.

The offering and the distribution of this announcement and other information in connection with the offer in certain jurisdictions may be restricted by law and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

This announcement does not constitute or form part of any offer or invitation to sell, or any solicitation of any offer to purchase any securities. Any offer and sale of any securities should only be made in compliance with the requirements of the UK Prospectus Regulation.

Any securities referred to herein have not been and will not be registered under the United States Securities Act of 1933 (as amended, the "Securities Act") and, subject to certain exceptions, may not be offered or sold within the United States or to United States persons. Any securities referred to herein are being offered and sold outside of the United States in reliance on Regulation S of the Securities Act.

Neither the content of any website referred to in this announcement nor the content of any website accessible from hyperlinks is incorporated into, or forms part of, this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRUWABROSUKURR
12
Date   Source Headline
18th Apr 20247:00 amRNSTrading Update
9th Feb 20245:23 pmRNSBlock Listing Six Monthly Return
26th Jan 202410:17 amRNSDirector/PDMR Notification
24th Jan 20247:00 amRNSPDMR dealing
5th Jan 20247:00 amRNSSale of residual economic interest in RMBS
19th Dec 20237:00 amRNSInterim Financial Results
30th Nov 20237:00 amRNSAnnouncement of Securitisation Settlement
22nd Nov 20234:42 pmRNSAnnouncement of Securitisation Transaction
4th Oct 20237:00 amRNSNotification of transactions by PCA with PDMR
28th Sep 202310:54 amRNSPublication of Final Terms
28th Sep 20238:19 amRNSFinal Terms Confirmation
22nd Sep 202310:26 amRNSIssue of shares to EBT and Total Voting Rights
18th Sep 202312:05 pmRNSResults of AGM
13th Sep 20231:23 pmRNSLaunch of 11.5% Bonds due 2026 and Exchange Offer
12th Sep 20231:42 pmRNSPublication of Base Prospectus
8th Sep 20239:57 amRNSConclusion of IT security event
5th Sep 202310:30 amRNSTrading update
4th Sep 202310:00 amRNSRoadshow announcement
25th Aug 20237:00 amRNSNotice of data breach
11th Aug 20238:59 amRNSBlock listing Interim Review
10th Aug 20231:55 pmRNSHolding(s) in Company
10th Aug 20231:47 pmRNSHolding(s) in Company
7th Aug 20234:28 pmRNSHolding(s) in Company
7th Aug 20234:26 pmRNSDirector/PDMR Notification
18th Jul 20237:00 amRNSLendInvest plc Full Year Financial Results FY23
3rd Jul 20237:00 amRNSAnnouncement of £500 million funding partnership
30th May 20237:00 amRNSLendInvest sells Buy-to-Let mortgage portfolio
5th May 202312:07 pmRNSPDMR Exercise of Share Options
5th May 202311:53 amRNSDirectorate Change
19th Apr 20233:22 pmRNSSale of residual economic interest in RMBS
13th Apr 20237:00 amRNSTrading Update
22nd Mar 202311:40 amRNSIssue of Shares to EBT and Total Voting Rights
1st Mar 20234:47 pmRNSSale of residual economic interest in RMBS
13th Feb 20237:00 amRNSBlock Listing Six Monthly Return
3rd Feb 20234:24 pmRNSDirector/PDMR Notification
17th Jan 20237:00 amRNSLendInvest secures funding from Lloyds Bank
19th Dec 20224:18 pmRNSNew £100 million financial partnership
19th Dec 20227:00 amRNSDirectorate Change
30th Nov 20227:00 amRNSInterim Financial Results
14th Oct 202210:41 amRNSDirector/PDMR Shareholding
11th Oct 202210:09 amRNSDirector/PDMR Shareholding
10th Oct 20227:00 amRNSTrading Update
8th Sep 20224:02 pmRNSResult of AGM
16th Aug 202210:56 amRNSPDMR Exercise of Share Options
12th Aug 20221:29 pmRNSSale of residual economic interest in RMBS
12th Aug 20227:00 amRNSBlock Listing Six Monthly Return
5th Aug 20227:55 amRNSNotice of Annual General Meeting
29th Jul 20223:14 pmRNSHolding(s) in Company
29th Jul 20223:12 pmRNSHolding(s) in Company
12th Jul 202212:38 pmRNSPublication of Base Prospectus
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.